{
    "ticker": "SGHT",
    "name": "Sight Sciences, Inc.",
    "description": "Sight Sciences, Inc. is a medical technology company focused on developing innovative solutions for the treatment of glaucoma and other eye diseases. Founded in 2015, the company aims to improve the standard of care and enhance the quality of life for patients suffering from ocular conditions. Sight Sciences is best known for its flagship product, the TearCare System, which provides a unique, non-invasive treatment for patients with meibomian gland dysfunction (MGD), a leading cause of evaporative dry eye. The company's technology leverages a proprietary thermal pulsation system to restore the natural function of the meibomian glands, thereby improving tear film stability and overall eye health. With a commitment to evidence-based practices, Sight Sciences is dedicated to advancing ophthalmic care through rigorous clinical research and innovative product development. The company is headquartered in Menlo Park, California, and is focused on creating solutions that are both effective and accessible, aiming to empower eye care professionals with the tools they need to deliver optimal patient outcomes.",
    "industry": [
        "Medical Devices",
        "Healthcare"
    ],
    "headquarters": "Menlo Park, California, USA",
    "founded": "2015",
    "website": "https://www.sightsciences.com",
    "ceo": "Paul Badawi",
    "social_media": {
        "twitter": "https://twitter.com/SightSciences",
        "linkedin": "https://www.linkedin.com/company/sight-sciences/"
    },
    "investor_relations": "https://investors.sightsciences.com",
    "key_executives": [
        {
            "name": "Paul Badawi",
            "position": "CEO"
        },
        {
            "name": "Dawn O'Leary",
            "position": "CFO"
        }
    ],
    "product_categories": [
        {
            "category": "Dry Eye Treatment",
            "products": [
                "TearCare System"
            ]
        },
        {
            "category": "Glaucoma Treatments",
            "products": [
                "Omni Surgical System"
            ]
        }
    ],
    "seo": {
        "meta_title": "Sight Sciences, Inc. | Innovative Eye Care Solutions",
        "meta_description": "Explore Sight Sciences, Inc., a leader in ophthalmic medical technology focused on developing innovative solutions for glaucoma and dry eye treatment.",
        "keywords": [
            "Sight Sciences",
            "Ophthalmic Technology",
            "Dry Eye Treatment",
            "Glaucoma",
            "Medical Devices"
        ]
    },
    "faq": [
        {
            "question": "What is Sight Sciences known for?",
            "answer": "Sight Sciences is known for its innovative medical technology solutions for treating glaucoma and dry eye."
        },
        {
            "question": "Who is the CEO of Sight Sciences?",
            "answer": "Paul Badawi is the CEO of Sight Sciences, Inc."
        },
        {
            "question": "Where is Sight Sciences headquartered?",
            "answer": "Sight Sciences is headquartered in Menlo Park, California, USA."
        },
        {
            "question": "What are Sight Sciences' main products?",
            "answer": "Sight Sciences' main products include the TearCare System and the Omni Surgical System."
        },
        {
            "question": "When was Sight Sciences founded?",
            "answer": "Sight Sciences was founded in 2015."
        }
    ],
    "competitors": [
        "ALRM",
        "STAA",
        "IRMD"
    ],
    "related_stocks": [
        "AAPL",
        "GOOGL",
        "AMZN",
        "MSFT"
    ]
}